Back to trial detailsIntake questionnaire
Outcomes of Physiologic Insulin Resensitization (PIR) in Patients With Chronic Kidney Disease and Type 2 Diabetes Mellitus
Applying to Arizona Kidney Disease and Hypertension Center · Phoenix, Arizona
Answer a few short questions to share with the research team.
0 of 3 answered